Biosimilars. [electronic resource]
- Lupus 05 2020
- 525-532 p. digital
Publication Type: Journal Article; Review
1477-0962
10.1177/0961203320910797 doi
Antibodies, Monoclonal, Humanized--therapeutic use Biosimilar Pharmaceuticals--therapeutic use Clinical Trials, Phase III as Topic Drug Approval Drug Development Humans Lupus Erythematosus, Systemic--drug therapy Rituximab--therapeutic use